These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1847706)

  • 1. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
    Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
    J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
    Dussaule JC; Michel C; Peraldi MN; Lecomte JM; Gros C; Mignon F; Ardaillou R
    Clin Sci (Lond); 1993 Jan; 84(1):31-9. PubMed ID: 8382131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
    Lecomte JM; Baumer P; Lim C; Duchier J; Cournot A; Dussaule JC; Ardaillou R; Gros C; Chaignon B; Souque A
    Eur J Pharmacol; 1990 Apr; 179(1-2):65-73. PubMed ID: 2163851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
    Jespersen B; Jensen L; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of atrial natriuretic factor [alpha-human ANF-(99-126)] in the hormonal and renal adaptation to sodium deficiency.
    Beland B; Tuchelt H; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1994 Jul; 79(1):183-8. PubMed ID: 8027224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
    Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
    Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EC 24.11 inhibition in man alters clearance of atrial natriuretic peptide.
    Richards AM; Wittert G; Espiner EA; Yandle TG; Frampton C; Ikram H
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1317-22. PubMed ID: 1827451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
    Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal effects of neutral endopeptidase inhibition in humans.
    Schmitt F; Martinez F; Ikeni A; Savoiu C; Natov S; Laborde K; Lacour B; Grünfeld JP; Hannedouche T
    Am J Physiol; 1994 Jul; 267(1 Pt 2):F20-7. PubMed ID: 7519405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients].
    Closas J; Genest J; Larochelle P; Cusson J; Gutkowska J; Hamet P; De Léan A; Thibault G; Cantin M
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():75-8. PubMed ID: 2847676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
    Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of urodilatin in patients with cirrhosis.
    Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
    Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.